Fundraising FoxCamford Capital — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.
BiotechDeep TechMedical DevicesCambridge, US
David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)
Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesF-Prime CapitalForesite CapitalGV (Google Ventures)+2 more
Cohesity provides cyber resilience software that helps organizations identify and protect the minimal critical datasets and systems needed to restart operations after ransomware attacks or disasters.
Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareSan Jose, US
Mohit Aron(Founder)inSanjay Poonen(CEO and President)inTIMOTHY ROBBINS(Executive Officer)inLORENZO MONTESI(Executive Officer)inROB SALMON(Executive Officer)inSanjay Poonen (CEO)(Founder)
Co-investors3Spoke CapitalAccelAdit Ventures Management, LlcArtis VenturesBattery VenturesCisco Investments+26 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.